- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Sharps Technology Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.07. | Sharps Technology ernennt Paul Danner zum Executive Chairman und aktualisiert Vorstandsrollen | 3 | Investing.com Deutsch | ||
| 03.07. | Sharps Technology Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 09.06. | Sharps Technology Inc: Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025 | 4 | GlobeNewswire (USA) | ||
| 04.06. | Aktie von Sharps Technology steigt nach ersten kommerziellen Lieferungen | 1 | Investing.com Deutsch | ||
| SHARPS TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 04.06. | Sharps Technology stock soars on first commercial shipments | 4 | Investing.com | ||
| 04.06. | Why Is Sharps Technology Stock Soaring On Wednesday? | 4 | Benzinga.com | ||
| 04.06. | Pre-market Movers: Baosheng Media, Sharps Technology, New Century Logistics, NewGenIvf Group, Bon Natural Life | 501 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.35 A.M. ET).In the Green Baosheng Media Group Holdings Limited (BAOS) is... ► Artikel lesen | |
| 04.06. | Sharps Technology Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 04.06. | Sharps Technology Inc: Sharps Technology Begins Shipments Across Three Customer Orders Under Previously Announced Purchase Agreements | 2 | GlobeNewswire (USA) | ||
| 22.05. | Sharps Technology Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.05. | Sharps Technology regains compliance with Nasdaq's listing rules | 1 | Seeking Alpha | ||
| 22.05. | Sharps Technology Inc: Sharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing Rule | 151 | GlobeNewswire (Europe) | NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen | |
| 15.05. | Sharps Technology Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 07.05. | Sharps Technology Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.04. | Pre-market Movers: Regulus Therapeutics, Jeffs' Brands, INVO Fertility, GeneDx Holdings, Sharps Technology | 770 | AFX News | TEMPE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.30 A.M. ET).In the Green Regulus Therapeutics Inc. (RGLS) is up over 132%... ► Artikel lesen | |
| 30.04. | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.04. | Sharps Technology receives $400K initial purchase order | 1 | Seeking Alpha | ||
| 24.04. | Sharps Technology announces 1-for-300 reverse stock split; shares down | 6 | Seeking Alpha | ||
| 24.04. | Sharps Technology Inc: Sharps Technology Announces Reverse Stock Split | 707 | GlobeNewswire (Europe) | NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen |
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| STRATEC | 28,700 | -0,17 % | EQS-PVR: STRATEC SE: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: STRATEC SE
STRATEC SE: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
14.07.2025 / 18:13 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,108 | +4,85 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,740 | +2,21 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| PING AN HEALTHCARE | 1,046 | -1,46 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand | HONG KONG and SHANGHAI, June 11, 2025 /PRNewswire/ -- The Ping An Good Doctor Brand Revamp & Ping An Healthcare Services Brand Launch Conference was held in Shanghai. Ping An Healthcare and... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,216 | +4,85 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,921 | +4,42 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
| VERU | 0,510 | -1,07 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen | |
| VOLITIONRX | 0,680 | -1,31 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
| EKSO BIONICS | 3,790 | +1,61 % | Ekso Bionics Holdings, Inc.: Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country | ||
| IMUNON | 0,484 | +2,98 % | Imunon, Inc.: IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan | Management provides Nasdaq Hearing Panel with a comprehensive executable plan for long term compliance LAWRENCEVILLE, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage... ► Artikel lesen | |
| BEYOND AIR | 2,500 | 0,00 % | XFRA 48L0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBEYOND AIR INC.... ► Artikel lesen | |
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,466 | -0,11 % | Novacyt S.A. - Launch of LightBench® Discover | ||
| FRESENIUS | 40,890 | -0,87 % | Aktie von Fresenius SE & Co. KGaA heute am Aktienmarkt kaum gefragt: Kurs fällt (41,21 €) | An der deutschen Börse notiert die Fresenius SE & Co. KGaA-Aktie derzeit ein wenig leichter. Die Aktie notiert zur Stunde bei 41,21 Euro. Der Anteilsschein von Fresenius+Co KgaA verzeichnet aktuell... ► Artikel lesen |
Das Unternehmen SHARPS TECHNOLOGY INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 5,800 Euro und damit -0,17 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHARPS TECHNOLOGY INC finden Sie auf Wallstreet Online.